![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/60 | |
C07K 1/107 | |||
C07C 309/42 | |||
A61K 47/54 | |||
C07K 14/605 | |||
C07K 14/62 |
(11) | Number of the document | 3534962 |
(13) | Kind of document | T |
(96) | European patent application number | 17800769.6 |
Date of filing the European patent application | 2017-11-07 | |
(97) | Date of publication of the European application | 2019-09-11 |
(45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2017/078457 |
Date | 2017-11-07 |
(87) | Number | WO 2018/083335 |
Date | 2018-05-11 |
(30) | Number | Date | Country code |
16197464 | 2016-11-07 | EP | |
17181621 | 2017-07-17 | EP |
(72) |
BIRKEBĘK JENSEN, Kim, DK
BERNT FREDRIK GUSTAFSSON, Magnus, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | DCHBS-ACTIVE ESTERS OF PEG COMPOUNDS AND THEIR USE |
DCHBS-ACTIVE ESTERS OF PEG COMPOUNDS AND THEIR USE |